€15.90
-0.14 (-0.87%)
EUR · as of 2026-08-17 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where IBAB.BR is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
3 interventional
government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan)NCT07152353Short term efficacy evaluationOpen-label · Treatment | Not applicable | Active, not recruiting | Device: Proton Beam Therapy (PBT) | Solid Tumor, Adult | 47 | Oct 2026 | ≤ 73 d | 2026-01-07 |
| Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)NCT07153094Short term efficacy evaluationOpen-label · Treatment | Not applicable | Active, not recruiting | Device: Proton Beam Therapy (PBT) | Solid Tumor, Adult | 47 | Oct 2026 | ≤ 73 d | 2026-01-16 |
| Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)NCT07137195Short term efficacy evaluationOpen-label · Treatment | Not applicable | Active, not recruiting | Device: Proton Beam Therapy (PBT) | Solid Tumor, Adult | 47 | 2026-09-05 | in 17 d | 2026-02-27 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19